Testing effectiveness (Phase 2)Not Yet RecruitingNCT07329569
What this trial is testing
Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial
Who this might be right for
Chemical BurnsOcular Burns
Fondation Ophtalmologique Adolphe de Rothschild 21